Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study-Reference-Cited by-同舟云学术

Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study

Published:2009-02 Issue:2 Volume:100 Page:357-362
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Ishizawa Kenichi,Ogura Michinori,Hamaguchi Motohiro,Hotta Tomomitsu,Ohnishi Kazunori,Sasaki Tsuneo,Sakamaki Hisashi,Yokoyama Hisayuki,Harigae Hideo,Morishima Yasuo

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2008.01047.x/fullpdf

Reference18 articles.

1. Tumor lysis syndrome: new therapeutic strategies and classification;Cairo;Br J Haematol,2004

2. Tumor lysis syndrome: pathophysiology, definition, and alternative treatment approaches;Del Toro;Clin Adv Hematol Oncol,2005

3. Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia;Cheson;J Clin Oncol,1998

4. Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries;Annemans;Leuk Lymphoma,2003

5. The status of allopurinol in the management of tumor lysis syndrome: a clinical review;Hagemeister;Cancer J,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022;International Journal of Clinical Oncology;2023-07-16

2. Survey of Anaphylaxis during Rasburicase Re-Administration in Patients with Hematological Malignancies Using a Japanese Claims Database;Current Oncology;2022-12-14

3. Role of Hypouricemic Agents in Tumor Lysis Syndrome: A Meta-Analysis;Journal of Pharmaceutical Research International;2021-06-25

4. Efficacy Evaluation of Mirogabalin for Chemotherapy-induced Peripheral Neuropathy;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2021-01-10

5. Anaphylactic Shock Following Repeated Rasburicase Treatment;Annals of Pharmacotherapy;2017-11-02